Home › Funds › Concentric Capital Strategies, LP › MSGS

Concentric Capital Strategies, LP position in MSGS

MADISON SQUARE GRDN SPRT COR · Consumer Discretionary

Concentric Capital Strategies, LP reported holding 38,517 shares of MSGS (MADISON SQUARE GRDN SPRT COR) in its Q3 2026 13F filing — a position valued at US$15.6M, representing 0.84% of its reported portfolio and ranking #16 among its reported holdings. Concentric Capital Strategies, LP has disclosed MSGS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)38.52K sh
Reported value held$15.61M
Portfolio Weight0.84%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Concentric Capital Strategies, LP's MSGS position evolved

Concentric Capital Strategies, LP first disclosed a stake in MSGS in Q3 2023 at 107,331 shares (US$18.9M). The position peaked in Q4 2025 at 120,256 shares, worth US$31.1M. Across 13 filings, Concentric Capital Strategies, LP increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 38,517 shares valued at US$15.6M — an increase of 7,279 shares quarter over quarter.. Notable position changes include a 135% increase in Q2 2024 (shares rose 11% over the following quarter), a 67% trim in Q1 2025 (shares rose 7% over the following quarter), a 202% increase in Q2 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 107.33K $18.92M New
Q4 2023 65.38K $11.89M Reduce
Q1 2024 45.55K $8.41M Reduce
Q2 2024 107.12K $20.15M Add
Q3 2024 61.22K $12.75M Reduce
Q4 2024 97.45K $21.99M Add
Q1 2025 31.82K $6.20M Reduce
Q2 2025 96.12K $20.08M Add
Q3 2025 109.24K $24.80M Add
Q4 2025 120.26K $31.10M Add
Q1 2026 49.47K $15.90M Reduce
Q2 2026 31.24K $12.55M Reduce
Q3 2026 38.52K $15.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MSGS and 13F data

MSGS (MADISON SQUARE GRDN SPRT COR) is a Consumer Discretionary company. 38 other funds we track also report a position in MSGS — the largest reported positions include Silver Lake Group, L.L.C. (US$579.7M), Gates Foundation Trust (US$238.1M), ARIEL INVESTMENTS, LLC (US$233.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MSGS

All MSGS fund holders →

FAQ

How long has Concentric Capital Strategies, LP held MSGS?

Concentric Capital Strategies, LP has disclosed MSGS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Concentric Capital Strategies, LP's current position in MSGS?

As of Q3 2026, Concentric Capital Strategies, LP holds 38.52K shares of MSGS (MADISON SQUARE GRDN SPRT COR), valued at $15.61M, representing 0.84% of its reported portfolio and ranking #16.

Has Concentric Capital Strategies, LP been buying or selling MSGS?

In the latest 13F filing (Q3 2026), Concentric Capital Strategies, LP increased its position in MSGS. The position peaked in Q4 2025 at 120.26K shares.

Which other funds hold MSGS?

Other major institutional holders of MSGS include Silver Lake Group, L.L.C., Gates Foundation Trust, ARIEL INVESTMENTS, LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.